Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Increase in ventilatory ratio indicates progressive alveolar damage and suggests poor prognosis in severe COVID-19: A single-center retrospective observational study

View ORCID ProfileNatsuko Kaku, View ORCID ProfileYu Nakagama, Michinori Shirano, Sari Shinomiya, Kazuhiro Shimazu, Katsuaki Yamazaki, Yoshito Maehata, Ryo Morita, View ORCID ProfileYuko Nitahara, Hiromasa Yamamoto, View ORCID ProfileYasumitsu Mizobata, View ORCID ProfileYasutoshi Kido
doi: https://doi.org/10.1101/2021.07.20.21260754
Natsuko Kaku
1Department of Parasitology, Research Center for Infectious Disease Sciences
4Department of Anesthesia and Intensive Care Medicine, Osaka City General Hospital, Osaka City Hospital Organization, 2-13-22 Miyakojima-hondori Miyakojima-ku, Osaka 534-0021 Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Natsuko Kaku
Yu Nakagama
1Department of Parasitology, Research Center for Infectious Disease Sciences
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yu Nakagama
Michinori Shirano
3Department of Infectious Diseases, Osaka City General Hospital, Osaka City Hospital Organization, 2-13-22 Miyakojima-hondori Miyakojima-ku, Osaka 534-0021 Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sari Shinomiya
4Department of Anesthesia and Intensive Care Medicine, Osaka City General Hospital, Osaka City Hospital Organization, 2-13-22 Miyakojima-hondori Miyakojima-ku, Osaka 534-0021 Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazuhiro Shimazu
4Department of Anesthesia and Intensive Care Medicine, Osaka City General Hospital, Osaka City Hospital Organization, 2-13-22 Miyakojima-hondori Miyakojima-ku, Osaka 534-0021 Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katsuaki Yamazaki
5Department of Anesthesiology, National Cerebral and Cardiovascular Center Hospital, 6-1 Kishibe-Shimmachi, Suita, Osaka 564-8565 Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshito Maehata
4Department of Anesthesia and Intensive Care Medicine, Osaka City General Hospital, Osaka City Hospital Organization, 2-13-22 Miyakojima-hondori Miyakojima-ku, Osaka 534-0021 Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryo Morita
3Department of Infectious Diseases, Osaka City General Hospital, Osaka City Hospital Organization, 2-13-22 Miyakojima-hondori Miyakojima-ku, Osaka 534-0021 Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuko Nitahara
1Department of Parasitology, Research Center for Infectious Disease Sciences
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yuko Nitahara
Hiromasa Yamamoto
2Department of Traumatology and Critical Care Medicine, Graduate School of Medicine, Osaka City University, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasumitsu Mizobata
2Department of Traumatology and Critical Care Medicine, Graduate School of Medicine, Osaka City University, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585 Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yasumitsu Mizobata
Yasutoshi Kido
1Department of Parasitology, Research Center for Infectious Disease Sciences
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yasutoshi Kido
  • For correspondence: kido.yasutoshi{at}med.osaka-cu.ac.jp
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The symptoms of severe COVID-19 are complex and wide-ranging even in intensive care unit (ICU) patients, who may successfully discontinue respiratory support in a short period or conversely require prolonged respiratory support. Damage in the lungs of COVID-19 patients is characterized pathologically as diffuse alveolar damage, the degree of which correlates with the severity of the disease. We hypothesized that the ventilatory ratio (VR), a surrogate parameter for the dead space fraction, might stratify the severity of COVID-19 and predict the successful discontinuation of respiratory support.

Methods Forty COVID-19 patients in our ICU were enrolled in this study. Respiratory variables were collected from 2 hours (day 0) after the initiation of respiratory support. We monitored the longitudinal values of VR and other respiratory parameters for 28 days. Patients successfully discontinued from respiratory support by day 28 of ICU stay were defined as the successfully discontinued group, while those who died or failed to discontinue were defined as the failed to discontinue group. VR and other respiratory parameters were compared between these groups.

Results Except for advanced age, prolonged ventilation period, and higher mortality in the failed to discontinue group, there were no significant differences between the groups in terms of any other background or respiratory parameter at 2 hours (day 0) after initiation of respiratory support. Longitudinal VR monitoring revealed significantly higher VR values in the failed to discontinue group than the successfully discontinued group on day 4 of respiratory support. Upon predicting the failure to discontinue respiratory support, the area under the receiver operating characteristic curve of VR values on day 4 of respiratory support was 0.748. A threshold of 1.56 achieved the highest predictive performance with a sensitivity of 0.667 and a specificity of 0.762. This threshold enabled the prediction of the successfully discontinued outcome at 0.810 of the negative predictive value.

Conclusions Elevated VR values on day 4 of respiratory support were predictive of successful discontinuation of respiratory support in patients with severe COVID-19. Longitudinal VR values after initiation of respiratory support can be used as a practical index to stratify severe COVID-19.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was funded by Japan Agency for Medical Research and Development (AMED) under Grant number JP20wm0125003 (Yasutoshi Kido), JP20he1122001 (Yasutoshi Kido), JP20nk0101627 (Yasutoshi Kido), and JP20jk0110021 (Yu Nakagama). This work was also supported by JSPS KAKENHI Grans Number JP21441824 (Natsuko Kaku). We also receive the COVID-19 Private Fund (to the Shinya Yamanaka laboratory, CiRA, Kyoto University). We received support from Osaka City University's "Special Reserves" fund for COVID-19.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was conducted under the approval of the Institutional Review Board of Osaka City University (#2020-003) and the Clinical Research Ethics Committee of the Osaka Municipal Hospital Organization (#2005020), Osaka, Japan.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • kaku.natsuko{at}med.osaka-cu.ac.jp

  • nakagama.yu{at}med.osaka-cu.ac.jp

  • shirano{at}wonder.ocn.ne.jp

  • sallyshinomiya{at}gmail.com

  • kazuhiro.shimazu.0211{at}gmail.com

  • ymzk_ktak{at}yahoo.co.jp

  • yoppymae{at}yahoo.co.jp

  • ryo10071007mrt{at}yahoo.co.jp

  • yuko.nitahara74{at}gmail.com

  • hyamamoto{at}med.osaka-cu.ac.jp

  • mizobata{at}med.osaka-cu.ac.jp

  • kido.yasutoshi{at}med.osaka-cu.ac.jp

Data Availability

The datasets used and analyzed during the current study are available in Microsoft Excel files titled 'Supplement Table 1-4'.

  • List of abbreviations

    ACE2
    angiotensin-converting enzyme 2
    ARDS
    acute respiratory distress syndrome
    AUC
    area under ROC curve
    BMI
    body mass index
    COVID-19
    Coronavirus disease 2019
    DAD
    diffuse alveolar damage
    Cstat
    static lung compliance
    FiO2
    the fraction of inspired oxygen
    IBW
    ideal body weight
    ICU
    intensive care unit
    MERS-CoV
    middle east respiratory syndrome coronavirus
    MV
    minute ventilation
    PaCO2
    the partial pressure of carbon dioxide
    PaO2
    the partial pressure of oxygen
    PCR
    polymerase chain reaction
    PEEP
    positive end-expiratory pressure
    Pplat
    plateau pressure
    P/F
    PaO2 / FiO2
    ROC
    receiver operating characteristic
    SARS-CoV
    severe acute respiratory syndrome coronavirus
    SARS-CoV-2
    severe acute respiratory syndrome coronavirus 2
    VD/VT
    dead space fraction
    VR
    ventilatory ratio
    VT
    tidal volume
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted July 22, 2021.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Increase in ventilatory ratio indicates progressive alveolar damage and suggests poor prognosis in severe COVID-19: A single-center retrospective observational study
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Increase in ventilatory ratio indicates progressive alveolar damage and suggests poor prognosis in severe COVID-19: A single-center retrospective observational study
    Natsuko Kaku, Yu Nakagama, Michinori Shirano, Sari Shinomiya, Kazuhiro Shimazu, Katsuaki Yamazaki, Yoshito Maehata, Ryo Morita, Yuko Nitahara, Hiromasa Yamamoto, Yasumitsu Mizobata, Yasutoshi Kido
    medRxiv 2021.07.20.21260754; doi: https://doi.org/10.1101/2021.07.20.21260754
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Increase in ventilatory ratio indicates progressive alveolar damage and suggests poor prognosis in severe COVID-19: A single-center retrospective observational study
    Natsuko Kaku, Yu Nakagama, Michinori Shirano, Sari Shinomiya, Kazuhiro Shimazu, Katsuaki Yamazaki, Yoshito Maehata, Ryo Morita, Yuko Nitahara, Hiromasa Yamamoto, Yasumitsu Mizobata, Yasutoshi Kido
    medRxiv 2021.07.20.21260754; doi: https://doi.org/10.1101/2021.07.20.21260754

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Intensive Care and Critical Care Medicine
    Subject Areas
    All Articles
    • Addiction Medicine (349)
    • Allergy and Immunology (668)
    • Allergy and Immunology (668)
    • Anesthesia (181)
    • Cardiovascular Medicine (2648)
    • Dentistry and Oral Medicine (316)
    • Dermatology (223)
    • Emergency Medicine (399)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
    • Epidemiology (12228)
    • Forensic Medicine (10)
    • Gastroenterology (759)
    • Genetic and Genomic Medicine (4103)
    • Geriatric Medicine (387)
    • Health Economics (680)
    • Health Informatics (2657)
    • Health Policy (1005)
    • Health Systems and Quality Improvement (985)
    • Hematology (363)
    • HIV/AIDS (851)
    • Infectious Diseases (except HIV/AIDS) (13695)
    • Intensive Care and Critical Care Medicine (797)
    • Medical Education (399)
    • Medical Ethics (109)
    • Nephrology (436)
    • Neurology (3882)
    • Nursing (209)
    • Nutrition (577)
    • Obstetrics and Gynecology (739)
    • Occupational and Environmental Health (695)
    • Oncology (2030)
    • Ophthalmology (585)
    • Orthopedics (240)
    • Otolaryngology (306)
    • Pain Medicine (250)
    • Palliative Medicine (75)
    • Pathology (473)
    • Pediatrics (1115)
    • Pharmacology and Therapeutics (466)
    • Primary Care Research (452)
    • Psychiatry and Clinical Psychology (3432)
    • Public and Global Health (6527)
    • Radiology and Imaging (1403)
    • Rehabilitation Medicine and Physical Therapy (814)
    • Respiratory Medicine (871)
    • Rheumatology (409)
    • Sexual and Reproductive Health (410)
    • Sports Medicine (342)
    • Surgery (448)
    • Toxicology (53)
    • Transplantation (185)
    • Urology (165)